Hensler Surgcial Products will be debuting the Hensler Bone Collector at the North American Spine Society’s (NASS) annual meeting in Boston on Wednesday, October 26 through Saturday, October 29.
Hensler Surgical to Launch Bone Collector
2 min read Premium comments
Secondary
“Our focus at Hensler Surgical is to launch innovative products that cut costs and improve patient care, ” said Sean Hensler, PAC, MMS (Neurosurgery) and founder of Hensler Surgical Products, in the August 9 news release. “Collecting bone chips is no easy task. In my 11 years of operating in the neurosurgical theater with Dr. Tom Melin, I have watched the scrub techs, first assists and even tried myself to quickly grab this bone from the Kerrison. The surgeons want the instrument cleaned and back quickly to continue working the case. This invaluable Autograft ends up all over the patient, floor, mayo stand and stuck in the sponges. It’s a pain. This instrument needs to be a rapid collection device to not hold up the case and not deter the techs from their very busy and invaluable task of running the mayo for the surgeon. I feel we have accomplished that. The Hensler Bone Collector is easy to use and handle, and serves to tremendously benefit both the patient and the surgical team.”
Asked about milestones, Hensler told OTW, “As this device was thought of during our own operations and being involved with the tedious process of cleaning and harvesting bone from the Kerrison, the first milestone would be definitive user testing, proving that the product worked very well. We set out with a 95% expectation of the device cleaning the Kerrison quickly and efficiently, but more accurately, was 98% in our formal testing. The device is in the tooling phase now and we expect to have sterile product for sale in the U.S. in 21 weeks and international sales anticipated Q2, 2017. The second milestone was that it was patented.
“We are very much so looking forward to introducing this new technology—and soon to be well accepted device—for both safety and autograft harvesting for any fusion procedure.”
Asked about plans for the next three to six months, Hensler commented, “The device is now in its final stages of tooling and production. We waited until the patent was approved and testing was perfected, which we have now.”
React:
Discussion
This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?
Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.
We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.
Join the conversation
Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.